Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Bass, Berry & Sims Releases Year-End Review of Securities and Shareholder Litigation

Publications

March 17, 2015

Welcome to the 2014 issue of Bass, Berry & Sims' Year-End Review of Securities and Shareholder Litigation.

This survey examines trends and developments in securities and shareholder litigation during 2014, with a focus on developments in the law governing corporate directors’ exercise of their fiduciary duties, particularly as they pertain to the adoption of bylaws and corporate change of control.

2014 was another busy and successful year for Bass, Berry & Sims' Securities and Shareholder Litigation Group. Our team spent the year defending lawsuits challenging mergers and other corporate control transactions, derivative litigation asserting breaches of fiduciary duty by directors, and class action lawsuits brought under federal and state securities laws, as well as ERISA.

Click below to view the Securities and Shareholder Litigation 2014 Year-End Review. We hope this review is useful. If you have any questions about the survey or would like additional information about the articles or the authors, please contact one of the attorneys listed. We look forward to working with you in the future.

Download Document - Securities & Shareholder Litigation 2014 Year-End Review

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.